PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2020-03-12

Date Title Company
12-Mar-2020 Invitation to MorphoSys' Year-End Results 2019 Conference Call on March 19, 2020 (news with additional features) MorphoSys AG
12-Mar-2020 CannTrust Provides Default Status Report CannTrust Holdings Inc.
12-Mar-2020 China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2019 China Biologic Products Holdings, Inc.
12-Mar-2020 Biofrontera AG: Biofrontera AG extends subscription period for mandatory convertible bonds Biofrontera AG
12-Mar-2020 Life sciences innovation on the rise: European Patent Office reports increase in patent filings in 2019 EPO Patent Index
12-Mar-2020 Oxabact® Treatment Combined With Intensive Dialysis Lowers Plasma Oxalate and Halts Disease Progression in a Patient With Severe Infantile Oxalosis OxThera AB
12-Mar-2020 FSD Pharma Begins Phase 1 In-human Safety and Tolerability Study of Ultra Micro-Palmitolylethanolamide (PEA) FSD Pharma
12-Mar-2020 Vifor Pharma Group reports strong growth in 2019, exceeding raised guidance Vifor Pharma Group
12-Mar-2020 Sareum notes publication of new research highlighting the therapeutic potential of SRA737 in a new drug combination targeting lung and colorectal cancers Sareum Holdings plc
12-Mar-2020 Acacia Pharma Announces Brief Extension of FDA Review Period for NDA for BYFAVO™, an Ultra-short Acting and Reversible Anesthetic for Procedural Sedation Acacia Pharma Group plc
12-Mar-2020 Zelluna Immunotherapy collaborates with Karolinska Institutet and enters into the NextGenNK Competence Center for allogeneic TCR based Natural Killer cell (TCR-NK) therapy development Zelluna Immunotherapy
12-Mar-2020 Positive results from Swedish study with DiviTum in metastatic breast cancer published in prestigious journal Biovica
12-Mar-2020 Major R&D milestones achieved in 2019 and strong clinical activity in 2020 Transgene
12-Mar-2020 Q BioMed Treats its First Patient in Commercial Setting Following Product Launch Q BioMed Inc
12-Mar-2020 Data visualisation tools developed by Zegami will be used by Oxford University for large cardiovascular clinical trials Zegami
12-Mar-2020 New study published in the Journal of Antimicrobial Chemotherapy-Antimicrobial Resistance shows benefit of cystitis service in community pharmacies Boots UK
12-Mar-2020 PAION AG: COSMO ANNOUNCES BRIEF EXTENSION OF FDA REVIEW PERIOD FOR NDA FOR REMIMAZOLAM PAION AG
12-Mar-2020 Toxys Raises €2 Million Financing for Global Expansion of its Unique Animal-Free Chemical Safety Tests B3C newswire
12-Mar-2020 Fabry Disease Drug Market to Exhibit 9.8% CAGR, Global Business Trends, Size, Share, Progress Insight, Statistics, Regional and Outlook 2026| Sanofi, Amicus Therapeutics, Inc, Moderna, Greenovation Biotech GmbH Wired Release
12-Mar-2020 PAION AG: COSMO ANNOUNCES BRIEF EXTENSION OF FDA REVIEW PERIOD FOR NDA FOR REMIMAZOLAM PAION AG